Yabao Pharmaceutical Group Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 800.5 million compared to CNY 694.3 million a year ago. Revenue was CNY 800.5 million compared to CNY 694.3 million a year ago.

Net income was CNY 107.42 million compared to CNY 71.39 million a year ago. Basic earnings per share from continuing operations was CNY 0.1395 compared to CNY 0.0927 a year ago. Diluted earnings per share from continuing operations was CNY 0.1395 compared to CNY 0.0927 a year ago.